Motley Fool Premium
  1. Stocks
    2. /
  2. Renalytix Plc (LSE: RENX)
    3. /

LSE:RENX (Renalytix Plc)

About RENX

Renalytix Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Renalytix Plc (LSE: RENX) Latest News

Investing Articles

Why has the Renalytix AI share price jumped?

| Christopher Ruane

On Thursday, the Renalytix AI share price grew by double digits. Christopher Ruane explains why and what he'll do on…

Read more »

Investing Articles

£500 to invest? Here’s how I’d look to make a 1,000% return investing in shares

| Andy Ross

Investing in shares can be hugely rewarding. To make big returns Andy Ross looks to smaller, more agile companies.

Read more »

Investing Articles

The Renalytix share price more than doubled in a year: what I’d do now

| Christopher Ruane

The Renalytix share price more than doubled in a year -- I know what I'll do now.

Read more »

Investing Articles

The price of this UK tech share is up over 80% in just the last month. Would I buy?

| Andy Ross

This UK tech share, which provides artificial intelligence diagnostics, has leapt recently in price and there could be potentially a…

Read more »